Trends in prevalence and outcome of heart failure with preserved ejection fraction, N Engl J Med, vol.355, pp.251-260, 2006. ,
Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction, Circulation, vol.124, pp.2491-501, 2011. ,
Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle, N Engl J Med, vol.350, pp.1953-1962, 2004. ,
Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy. Systolic versus diastolic determinants, Circulation, vol.88, pp.1893-906, 1993. ,
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, JAMA, vol.289, pp.194-202, 2003. ,
Impaired left atrial function in heart failure with preserved ejection fraction, Eur J Heart Fail, vol.16, pp.1096-103, 2014. ,
Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction, Circ Heart Fail, vol.8, pp.295-303, 2015. ,
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota, Circulation, vol.115, pp.1982-90, 2007. ,
Left atrium in heart failure with preserved ejection fraction: structure, function, and significance, Circ Heart Fail, vol.7, pp.1042-1051, 2014. ,
Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction, J Am Coll Cardiol, vol.49, pp.198-207, 2007. ,
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation, J Am Coll Cardiol, vol.62, pp.263-71, 2013. ,
State of the Art: Newer biomarkers in heart failure, Eur J Heart Fail, vol.17, pp.559-69, 2015. ,
Soluble ST2 may possess special superiority as a risk predictor in heart failure patients, Int J Cardiol, vol.186, pp.146-153, 2015. ,
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction, J Am Heart Assoc, vol.6, 2017. ,
Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction, Eur J Heart Fail, vol.11, pp.198-204, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00911681
Effective arterial elastance as index of arterial vascular load in humans, Circulation, vol.86, pp.513-534, 1992. ,
Noninvasive single-beat determination of left ventricular end-systolic elastance in humans, J Am Coll Cardiol, vol.38, pp.2028-2062, 2001. ,
Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans, Am J Physiol, vol.274, pp.500-505, 1998. ,
Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study, Circulation, vol.102, pp.1788-94, 2000. ,
Single-beat estimation of end-diastolic pressurevolume relationship: a novel method with potential for noninvasive application, Am J Physiol Heart Circ Physiol, vol.291, pp.403-415, 2006. ,
Statistical methods for medical and biological students ,
, , 1940.
Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI, Circ Cardiovasc Imaging, vol.3, issue.23, pp.231-240, 2010. ,
Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse, Am J Cardiol, vol.111, pp.595-601, 2013. ,
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study, Circ Heart Fail, vol.9, 2016. ,
Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load, J Am Coll Cardiol, vol.52, pp.2166-74, 2008. ,
The role of left atrial function in diastolic heart failure, Circ Cardiovasc Imaging, vol.2, pp.6-9, 2009. ,
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure, Cardiovasc Res, vol.63, pp.236-280, 2004. ,
Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion, Cardiovasc Res, vol.35, pp.138-185, 1997. ,
Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation, Heart, vol.96, pp.1311-1318, 2010. ,
Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations, Circulation, vol.107, pp.714-734, 2003. ,
Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction, Circ Heart Fail, vol.9, p.2763, 2016. ,
, , vol.3, p.2335
, ST2 (ng/mL) 32 (Q1:24, vol.3, p.48
, Hemoglobin
, White blood cell count, vol.9, issue.10, p.9
,
, Table 2. Cardiac and vascular geometric and functional measures in the two groups stratified according to LA-GS. BMI, body mass index; SBP, systolic blood pressure, DBP
,
, EDVi, end-diastolic volume index
, ESVi, end-systolic volume index
LV mass index ,
, EF, ejection fraction; LV-GLS, LV global longitudinal strain
, SVi, stroke volume index
,
ratio between the early diastolic inflow velocity (E) to the inflow velocity due to atrial contraction (A) ,
, e' mean, mean value of early myocardial velocity in LV basal septal and lateral wall
, non-invasive; tau, time constant of LV isovolumic relaxation; ?, diastolic stiffness constant describing the steepness of the EDPVR curve
,
,
left atrial end-systolic volume; LA-GS, left atrial global longitudinal strain; LA EF, left atrial ejection fraction ,
, TAPSE, tricuspid annular plane systolic excursion; NT-proBNP, Nterminal pro-brain natriuretic peptide
, ST2, soluble suppression of tumorigenicity-2 receptor; eGFR, estimated glomerular filtration rate; NS, non-significant (p ? 0.05). Data are provided as mean ± SD followed by patient number in brackets; or median values followed by 1st and